PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for September 16, 2006 Subscribe to this News Feed    
 

Piribo: Accelerating Patient Recruitment in Clinical Trials, New Publication Announcement

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Accelerating Patient Recruitment in Clinical Trials”.

(PRWEB) September 16, 2006 -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Accelerating Patient Recruitment in Clinical Trials”. http://www.piribo.com/publications/research_development/clinical_trials/accelerating_patient_recruitment_clinical_trials.html

All pharmaceutical companies want to find cost savings. The industry conducts large numbers of clinical trials each year. Regulatory requirements, as well as other scientific and marketing needs, mean that many of these studies continue to need ever-larger numbers of patients. The cost of running trials is now approaching 30% of pharmaceutical companies' entire drug development budgets. However, 75% of patient studies fail to make their timelines, often causing expensive delays in regulatory approval and market launch. Slow patient recruitment represents a major reason for this, as does poor retention of patients within ongoing clinical trials. Close scrutiny of, and adherence to, a variety of factors that promote timely patient recruitment, however, mean that pharmaceutical companies have tangible mechanisms that can substantially enhance their profi tability. The 2nd Annual Conference on Accelerating Patient Recruitment in Clinical Trials, held in London 27-28 March 2006, organised by SMi, discussed a diverse range of approaches now used by some companies and their Contract Research Organisations to adhere to timelines, to shorten them, and to try to identify recently evolving best practices.

This KeywordPharma Conference Insights review, published by NetworkPharma Ltd, provides analysis of the pertinent issues raised in selected presentations made at this event, discussing proven strategies to maximise patient recruitment, tools to assist the process, investigator-site selection and public perceptions of clinical trials. It makes clear why the old method of opportunism in patient recruitment is not effective, and looks at why companies are starting to abandon expensive advertising campaigns in favour of evidence-based patient recruitment strategies.

From a business point of view, optimising patient recruitment and retention, with the aim of getting new products on the market as soon as possible, now represents an important, achievable goal for all pharmaceutical companies.

“Accelerating Patient Recruitment in Clinical Trials” is available from Piribo. For more information go to: http://www.piribo.com/publications/research_development/clinical_trials/accelerating_patient_recruitment_clinical_trials.html

Piribo Product ID: NWP001

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Brendt Sheen
PIRIBO LTD
+44 207 060 7474
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.